PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-04-14

Date Title Company
14-Apr-2026 Chemify Founder Publishes Three Papers Validating Chemputation To Reimagine New Chemical Discovery and Development Chemify
14-Apr-2026 Scientists develop new way to determine which patients will respond best to bowel cancer treatment The Institute of Cancer Research
14-Apr-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
14-Apr-2026 Clean Cells and Naobios showcase complete end-to-end viral vaccines and vector solutions at BIO KOREA 2026 Clean Cells
14-Apr-2026 Transgene Completes Patient Randomization in Phase 2 Part of Clinical Trial Evaluating TG4050 in the Adjuvant Treatment of Head and Neck Cancer Transgene
14-Apr-2026 Bayer receives MHRA approval for Kerendia®▼(finerenone) in adults with heart failure with LVEF ≥40% Bayer
14-Apr-2026 Mestag Therapeutics Selected to Present Targeted LTBR Agonist MST 0312 in Late Breaking Session at AACR Annual Meeting Mestag Therapeutics
14-Apr-2026 Epitopea Strengthens Scientific Advisory Board with Appointment of Leading Authority in Cancer, Lisa Butterfield Epitopea
14-Apr-2026 PEPITEM ‘replacement therapy’ shows potential for early-stage inflammatory arthritis University of Birmingham
14-Apr-2026 Clean Food Group: £4.5 Million Investment Led by Clean Growth Fund and New Agrarian Businesswire
14-Apr-2026 Cambridge Cognition Results for the year ended 31 December 2025 Cambridge Cognition
14-Apr-2026 One in Three Men Die Early - Androlabs Applauds new £6.3m Fund to Tackle a Worsening Crisis Androlabs
14-Apr-2026 Ceva Animal Health appoints Sébastien Huron as Deputy Chief Executive Officer Ceva Animal Health
14-Apr-2026 Preclinical data on novel NK-Cell engager to be presented at the AACR Annual Meeting 2026 Oncopeptides
14-Apr-2026 Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria Sanofi, Regeneron
14-Apr-2026 Forge Genetics announces licensing deal to explore Forge Editing in pharmaceutical uses Forge Genetics
14-Apr-2026 PannTheraPi Announces Significant Clinical Development and Strategic Milestones PannTheraPi
14-Apr-2026 Ondine Biomedical Inc. Steriwave ICU Study Shows 39.5% Pneumonia Drop Ondine Biomedical
14-Apr-2026 MHRA Approves New High Dose Regimen of SPINRAZA™ (nusinersen) for Spinal Muscular Atrophy Biogen
14-Apr-2026 Eurofins to Divest Its Electrical & Electronic Testing Business Businesswire